News | Clinical Decision Support | April 27, 2016

Imaging Advantage Launches X-ray Artificial Intelligence Engine Initiative

Cloud-based radiology provider working with leading scientists to develop deep-learning algorithm to pre-read digital X-rays and identify potential areas of injury and disease

April 27, 2016 — Imaging Advantage LLC, platform provider of cloud-based radiology service, announced the launch of a machine learning research initiative titled Singularity Healthcare. The initiative is being conducted with leading faculty members from the Massachusetts Institute of Technology and Harvard Medical School/Massachusetts General Hospital. 

Singularity is developing an artificial intelligence engine to be seamlessly incorporated into IA's proprietary exam routing technology. The engine will instantly pre-read digital X-rays and identify potential areas of injury and disease, while continuously learning from IA's expanding database of 7 billion images. The algorithm will be applied before X-ray images are routed to one of the 500 board certified radiologists connected in the cloud to IA's platform.  

Combining business and academic power, Singularity seeks to provide a widely applicable solution to problems central to the U.S. healthcare system. X-ray exams constitute 50 percent of all radiology tests in healthcare, and radiology is the significant limiting factor in hospital emergency department patient flow and treatment.

The initiative brings together leading academicians from two renowned programs at MIT and Harvard.  SP Kothari, Ph.D., Gordon Y Billard Professor of Management at MIT's Sloan School of Management will lead the project, working in conjunction with Sanjay Saini, M.D., professor of radiology at Harvard Medical School and vice chairman of radiology at Massachusetts General Hospital (MGH) who will advise on imaging quality and utility to radiologists, and Kalyan Veeramachaneni, Ph.D., principal research scientist at MIT's Institute for Data, Systems and Society.

Kothari added, "We have a number of opportunities for research and innovation at MIT, but were particularly intrigued by the bold initiative proposed by Imaging Advantage. Given IA's platform approach to healthcare delivery, national scale and significant imaging dataset, and the contribution of Dr. Saini from MGH, one of the leading global radiology teaching and research institutions, the project is not only achievable, but also has potential to touch nearly every person in world.  This is how we think artificial intelligence and deep learning should be developed and deployed."  

"The proposed deep-learning solution combines all layers of machine learning into a single pipeline, and then optimizes and meshes with other machine-learning algorithms on top of it," said Veeramachaneni.  "Starting this endeavor with the enormous trove of metadata in Imaging Advantage's archives, we can learn how decisions made at the initial, raw representation stage impact the final predicted accuracy efficacy."

IA hopes to eventually expand the technology to computed tomography (CT), magnetic resonance imaging (MRI) and other areas of time-consuming diagnostic testing.

Singularity Healthcare is being launched in Q2 of 2016. According to Kothari, "Given the advances in the field of artificial intelligence that have taken place at MIT and elsewhere, and Imaging Advantage's scale, we are not only optimistic about a successful outcome, but expect it to be realized on an accelerated schedule."

For more information: www.imagingadvantage.com

Related Content

MD Buyline, James Laskaris, four medical technology innovations, very near future
Feature | Cardiac Imaging| January 17, 2017
James Laskaris, emerging technology analyst at MD Buyline, recently offered his perspective on new medical technology...
PET/CT, atherosclerotic plaque detection, Stanford University

Application of dual-modality optical and PET/CT activity-based probe in experimental carotid inflammation model. Coronal noninvasive PET/CT scans of (A) healthy and (B) diseased mice with and without ligated carotid arteries respectively. Inset images show optical ex vivo florescence imagining of (A) healthy and (B) diseased carotid arteries.  PET/CT and optical images courtesy of Xiaowei Ma, Toshinobu Saito and Nimali Withana.

News | PET-CT| November 01, 2016
Researchers at Stanford University have demonstrated for the first time the use of a dual optical and positron emission...
News | Analytics Software| October 31, 2016
In an effort to improve patient care, Children's Hospital of Philadelphia's (CHOP) Information Services team is using...
GE Healthcare, Revolution CT, Whisper Drive, RSNA 2016, cardiac imaging
News | CT Angiography (CTA)| October 31, 2016
At the 2016 annual meeting of the Radiological Society of North America (RSNA 2016), GE Healthcare will introduce the...
Philips, Lumify smart-device ultrasound, S4-1 cardiac transducer, RSNA 2016
Technology | Cardiovascular Ultrasound| October 14, 2016
Philips announced at The American College of Emergency Physicians' (ACEP) annual meeting that it has received 510(k)...
Toshiba CT, picking a CT scanner, choosing a CT scanner, CT 101, what to look for in CT scanners, Aquilion ONE ViSION

The Toshiba Aquilion One Vision system is among the new generation of CT systems on the market that offers several dose lowering technologies and a hardware/software combination to enhance image quality over previous-generation scanners.

Feature | CT Angiography (CTA)| October 14, 2016 | Dave Fornell
As hospitals begin replacing their first-generation 64-slice computed tomography (CT) scanners after a decade of use,
Robert M. Califf, FDA commissioner, future of cardiovascular medicine, JACC column
News | Business| September 23, 2016
Technology advances coupled with increased use of social media and personal devices could offer new possibilities for...
GE Healthcare, Mission Health, innovation collaboration, outcomes-based agreement, imaging, business
News | Business| August 30, 2016
August 30, 2016 — Mission Health and GE Healthcare announced a novel, 10-year...
Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC

The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves. 

Feature | August 05, 2016 | Dave Fornell
 
CT angiography, CTA, coronary CT, cardiac CT, SCCT, society of cardiovascular computed tomography, cardiac imaging
Feature | CT Angiography (CTA)| August 03, 2016 | Dave Fornell
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting offers an in-depth review of all aspects of c
Overlay Init